Skip to main content
Macrogen, Inc. logo

Macrogen, Inc. — Investor Relations & Filings

Ticker · 038290 ISIN · KR7038290003 KO Professional, scientific and technical activities
Open in API
Filings indexed 352 across all filing types
Latest filing 2024-03-21 Audit Report / Informat…
Country KR South Korea
Listing KO 038290

About Macrogen, Inc.

https://www.macrogen.com/en/main

Macrogen, Inc. is a biotechnology company specializing in precision medicine and genomic analysis. It provides a comprehensive suite of services, including Next-Generation Sequencing (NGS), Sanger sequencing, and spatial transcriptome analysis, to a global client base. The company's core activities are focused on three key areas: Research and Data Analysis, offering fast and accurate genomic services to the scientific community; Clinical Diagnostics, advancing disease prediction through the integration of genomic and medical big data; and Personal Healthcare, providing genetic tests for wellness, nutrition, and disease risk assessment. By combining its extensive genomic expertise with big data and AI, Macrogen aims to deliver hyper-personalized healthcare solutions and innovate in the field of future medicine.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing titled '감사보고서 제출' (Submission of Audit Report) from Macrogen. It provides a summary of financial data, audit opinions, and key financial metrics (assets, liabilities, equity, profit/loss) for the current and previous fiscal years. While it contains financial data, it is a standard regulatory disclosure announcement in the Korean market (DART system) confirming the receipt and submission of the audit report, rather than the full, multi-page audited financial statement document itself. Therefore, it is classified as a Regulatory Filing (RNS). FY 2023
2024-03-21 Korean
사업보고서 (2023.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Macrogen Inc. for the fiscal year ending December 31, 2023. It includes the independent auditor's report from Samil PricewaterhouseCoopers, the consolidated financial statements (Statement of Financial Position, Statement of Comprehensive Income, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes. It is not an Annual Report (10-K) as it focuses specifically on the audit and financial statements rather than the full business activity report, and it is not an announcement (RPA) as it contains the full financial data. FY 2023
2024-03-21 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Macrogen. It contains the agenda for the 28th Annual General Meeting, including reports on financial statements, director appointments, and remuneration limits. It also includes detailed management information, financial statements (balance sheet, income statement, etc.), and governance details (board activity). In the context of financial filings, this document is a Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on agenda items for the upcoming meeting.
2024-02-29 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (often referred to as a Proxy Solicitation Statement). It contains information regarding the upcoming Annual General Meeting (AGM), including the purpose of the meeting, proxy solicitation details, and financial statements (balance sheets, income statements) for the fiscal year 2023. While it contains financial data, it is not an Annual Report (10-K) or an Interim Report (IR) itself, but rather a proxy solicitation document used to gather votes for the AGM. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2024-02-29 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Macrogen. It details the date, location, agenda items (financial statement approval, director appointments, and remuneration limits), and provides biographical details for the director nominees. This type of document is a standard proxy solicitation material used to inform shareholders of upcoming meeting business and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2024-02-28 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the KRX (Korea Exchange) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company is holding its AGM on a date that coincides with other companies' meetings, citing audit schedules and reporting obligations. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or a proxy statement, it falls under the general regulatory filing category.
2024-02-28 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.